VTV vs XBI

Vanguard Value ETF vs SPDR S&P Biotech ETF

Quick take
  • VTV has the lower expense ratio at 0.03% vs 0.35% for XBI.
  • VTV pays a higher dividend yield (1.88%).

Side-by-side metrics

MetricVTVXBI
Expense ratio
Annual fee. Lower is better.
0.03%0.35%
Dividend yield
Trailing 12-month yield.
1.88%0.36%
AUM
Assets under management — bigger funds are typically more liquid.
$254.46B$10.73B
YTD return
15.16%33.79%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.691.10
P/E ratio
21.68
Last price
$219.20$164.01
Inception
Issuer
VanguardState Street

VTV top holdings

Top holdings · VTV
MUMicron Technology Inc4.15%
JPMJPMorgan Chase & Co2.87%
BRK-BBerkshire Hathaway Inc Class B2.81%
XOMExxon Mobil Corp2.30%
JNJJohnson & Johnson2.06%
WMTWalmart Inc1.93%
INTCIntel Corp1.74%
CSCOCisco Systems Inc1.63%
CATCaterpillar Inc1.55%
ABBVAbbVie Inc1.46%
Sector breakdown · VTV
Real Estate2.7%
Consumer Cyclical4.0%
Basic Materials3.0%
Consumer Defensive8.9%
Technology16.9%
Communication Services3.1%
Financial Services21.5%
Utilities4.8%
Industrials13.5%
Energy7.4%
Healthcare14.2%

XBI top holdings

Top holdings · XBI
APGEApogee Therapeutics Inc1.49%
MRNAModerna Inc1.41%
TWSTTwist Bioscience Corp1.41%
ORKAOruka Therapeutics Inc1.38%
KYMRKymera Therapeutics Inc Ordinary Shares1.36%
VKTXViking Therapeutics Inc1.30%
PRAXPraxis Precision Medicines Inc Ordinary Shares1.29%
ERASErasca Inc1.27%
RVMDRevolution Medicines Inc Ordinary Shares1.20%
RYTMRhythm Pharmaceuticals Inc1.20%
Sector breakdown · XBI
Financial Services0.5%
Healthcare99.5%

About VTV

VTV (Vanguard Value ETF) is Large-cap US value stocks. Managed by Vanguard, the fund carries $254.5B in assets under management, an expense ratio of 0.03%, a dividend yield of 1.88%. Its largest holding is Micron Technology Inc (MU), which represents 4.1% of the portfolio. Real Estate is the fund's largest sector exposure at 2.7%.

About XBI

XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.